satellite_symposium_300x300
Description

Learning Objectives

  • Recognize spasticity in children with CP and strategies to establish individualized treatment goals.
  • Assess the efficacy and safety data on available pharmacological and non-pharmacological strategies to manage spasticity in children with CP.
  • Evaluate the use of BoNT as part of individualized treatment plans for managing spasticity in children with CP.

Speakers:

Katharine Alter, MD, FAAPMR
Mark Gormley, Jr., MD, FAAPMR
Mauricio R. Delgado, MD
Tags